Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117 |
---|---|
Full Title | COG-ANHL12P1 A Randomized Phase II study of Brentuximab Vedotin (NSC 749710) and Crizotinib (NSC 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND 117117 |
Disease/Condition | Pediatric Hematology/Oncology |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Jonathan Gill |
Contact Name | Joyce Brown |
Contact Email | jivanova@montefiore.org |
Protocol Number | IRB# 2015-4858 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Enrolling |
Adult Clinical Trial | No |
Pediatric Clinical Trial | No |
Adult, Pediatric, Both | Adult |